These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions. Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151 [TBL] [Abstract][Full Text] [Related]
28. Dual-point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics. Guo D; van Dorp EJ; Mulder-Krieger T; van Veldhoven JP; Brussee J; Ijzerman AP; Heitman LH J Biomol Screen; 2013 Mar; 18(3):309-20. PubMed ID: 23093571 [TBL] [Abstract][Full Text] [Related]
29. Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds. Sykes DA; Jain P; Charlton SJ Mol Pharmacol; 2019 Sep; 96(3):378-392. PubMed ID: 31436538 [TBL] [Abstract][Full Text] [Related]
30. Considerations for improved performance of competition association assays analysed with the Motulsky-Mahan's "kinetics of competitive binding" model. Georgi V; Dubrovskiy A; Steigele S; Fernández-Montalván AE Br J Pharmacol; 2019 Dec; 176(24):4731-4744. PubMed ID: 31444916 [TBL] [Abstract][Full Text] [Related]
31. Graphic presentation and analysis of inhibition data from ligand-binding experiments. Bylund DB Anal Biochem; 1986 Nov; 159(1):50-7. PubMed ID: 3028212 [TBL] [Abstract][Full Text] [Related]
32. A partially automated radioligand binding assay system for use in clinical and pharmaceutical research. Liebl B; Anhäupl T; Haen E; Günster B; Georgieff M J Recept Res; 1993; 13(1-4):369-78. PubMed ID: 8383759 [TBL] [Abstract][Full Text] [Related]
33. Ligand-binding studies: old beliefs and new strategies. Rovati GE Trends Pharmacol Sci; 1998 Sep; 19(9):365-9. PubMed ID: 9786024 [TBL] [Abstract][Full Text] [Related]
34. A rigorous multiple independent binding site model for determining cell-based equilibrium dissociation constants. Drake AW; Klakamp SL J Immunol Methods; 2007 Jan; 318(1-2):147-52. PubMed ID: 17141800 [TBL] [Abstract][Full Text] [Related]
35. Practical aspects of radioligand binding. McKinney M; Raddatz R Curr Protoc Pharmacol; 2006 Jul; Chapter 1():Unit1.3. PubMed ID: 22294165 [TBL] [Abstract][Full Text] [Related]
37. Error analysis on parameter estimates in the ligand-receptor model: application to parameter imaging using PET data. Millet P; Delforge J; Pappata S; Syrota A; Cinotti L Phys Med Biol; 1996 Dec; 41(12):2739-56. PubMed ID: 8971966 [TBL] [Abstract][Full Text] [Related]
38. Identification of insulin receptor systems: assessing the impact of model selection and measurement error on precision of parameter estimates using Monte Carlo study. Hovorka R; Hilgertova J J Theor Biol; 1991 Aug; 151(3):367-83. PubMed ID: 1943148 [TBL] [Abstract][Full Text] [Related]
39. SIMUL: an accurate method for the determination of receptor subtype proportions using a personal computer. Williams DW; Summers RJ Comput Methods Programs Biomed; 1990 Jun; 32(2):137-9. PubMed ID: 2397637 [TBL] [Abstract][Full Text] [Related]
40. A chemical kinetic model for ligand binding to identical and independent binding sites in vivo. Bond JP; Notides AC Anal Biochem; 1988 Nov; 175(1):238-51. PubMed ID: 2854373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]